Concepedia

Thomas J. Semrad

TJ

25

Publications

969

Citations

15

H-Index

2007

Active since

Affiliations

University of California, Davis(Current)

UC Davis Comprehensive Cancer Center

University of Southern California

Fred Hutch Cancer Center

University of California Davis Medical Center

Thomas J. Semrad is an author at University of California, Davis specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2021

25

Publications

25

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma

Thomas J. Semrad, Robert T. OʼDonnell, Ted Wun et al. · Journal of neurosurgery · 2007 · 282 citations

Randomized trial of irinotecan and cetuximab with or without vemurafenib in <i>BRAF</i>-mutant metastatic colorectal cancer (SWOG 1406).

Scott Kopetz, Shannon McDonough, Van K. Morris et al. · Journal of Clinical Oncology · 2017 · 107 citations

, , +15

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors

Benjamin Tomlinson, James A. Thomson, John S. Bomalaski et al. · Clinical Cancer Research · 2015 · 88 citations · Full text

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Roy S. Herbst, Mary W. Redman, Edward S. Kim et al. · The Lancet Oncology · 2017 · 74 citations · Full text

, , +8

Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion

David J. Adelstein, Nofisat Ismaila, Jamie A. Ku et al. · Journal of Clinical Oncology · 2019 · 70 citations

Rows per page

1–5 of 25